Processing 00000000.tx.1: No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease Andrew B. 

Phrase: "No association between the K variant of the butyrylcholinesterase gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004083:Association [Mental Process]
   739   C0439849:Association [Qualitative Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "pathologically confirmed Alzheimer's disease Andrew B."
Processing 00000000.tx.2: Singleton1,2*, Graeme Smith1,2, Alison M. 

Phrase: "Singleton1,"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "*,"

Phrase: "Graeme Smith1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Alison M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: Gibson1,2, Rebecca Woodward1,2, Robert H. 

Phrase: "Gibson1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Rebecca Woodward1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Robert H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: Perry3, Paul G. 

Phrase: "Perry3,"

Phrase: "Paul G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.5: Ince1,2,3, James A. 

Phrase: "Ince1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "James A."
Processing 00000000.tx.6: Edwardson1,2, Christopher M. 

Phrase: "Edwardson1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Christopher M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.7: Morris1,2 1MRC Neurochemical Pathology Unit, 2Institute for the Health of the Elderly and 3Department of Neuropathology, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne, NE4 6BE UK Received December 2, 1997; 

Phrase: "Morris1,"

Phrase: "2 1MRC Neurochemical Pathology Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0439148:Unit [Quantitative Concept]
   804   C1519795:Unit [Quantitative Concept]
   804   C1704753:Unit [Manufactured Object]
   804   C1880519:Unit [Quantitative Concept]

Phrase: "2Institute for the Health of the Elderly"

Phrase: "and"

Phrase: "3Department of Neuropathology,"

Phrase: "Newcastle General Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Westgate Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442650:Road [Manufactured Object]

Phrase: "Newcastle upon Tyne,"

Phrase: "NE4 6BE UK"

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "December 2,"

Phrase: "1997"

Phrase: ";"
Processing 00000000.tx.8: Revised and Accepted February 6, 1998 The polymorphic K variant of the butyrylcholinesterase (BCHE-K) gene recently has been demonstrated to have an elevated frequency in Alzheimer's disease (AD) patients carrying the [epsis]4 allele of the apolipoprotein (APO E) gene when compared with a control population. 

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted February 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1998"

Phrase: "The polymorphic K variant of the butyrylcholinesterase (BCHE-K) gene recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205419:Variant [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "an elevated frequency in Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "(AD) patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the [epsis"

Phrase: "]4 allele of the apolipoprotein (APO E) gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0002085:Allele [Gene or Genome]
           allelic gene

Phrase: "when"

Phrase: "compared with a control population."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0032662:control population [Occupation or Discipline]
   760   C0032659:Population [Quantitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1257890:Population [Population Group]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.9: We therefore genotyped a large series of pathologically confirmed AD patients and controls to confirm this association. 

Phrase: "We therefore"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "a large series of pathologically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]
Processing 00000000.tx.10: We found no change in the frequency of this genetic variant, either in the AD group as a whole or in early- or late-onset patients when compared with age-matched controls. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no change in the frequency of this genetic variant,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0442739:No change [Finding]
   764   C1548568:No change [Intellectual Product]
   762   C1705285:Genetic Change [Cell or Molecular Dysfunction]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "either in the AD group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "as a whole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444667:Whole [Quantitative Concept]

Phrase: "or in early-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1279919:Early [Temporal Concept]

Phrase: "or"

Phrase: "late-onset patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "when"

Phrase: "compared with age-matched controls."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.11: Stratification of these groups with reference to the APO E [epsis]4 allele also showed no difference between AD and control groups. 

Phrase: "Stratification of these groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514983:Stratification [Research Activity]

Phrase: "with reference to the APO E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4 allele also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no difference between AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "control groups."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0009932:Control Groups [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.12: To determine if a biological effect were present, we also looked at senile plaque and neurofibrillary tangle densities in the frontal, temporal, parietal and occipital cortices in AD patients either carrying or not carrying a copy of the K variant. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "a biological effect"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205460:biological [Qualitative Concept]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "we also"

Phrase: "looked at senile plaque"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0333463:Senile plaque [Acquired Abnormality]
           plaque
   770   C0011389:Plaque [Disease or Syndrome]
   770   C0332461:Plaque [Finding]
   770   C0392079:Senile [Finding]
   737   C0233426:look [Organism Attribute]
   715 E C0231337:Old age [Finding]
   715 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "neurofibrillary tangle densities in the frontal, temporal, parietal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0178587:densities [Quantitative Concept]

Phrase: "and"

Phrase: "occipital cortices in AD patients either carrying"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C1184145:Occipital [Body Location or Region]
   745   C0028785:Occipital cortex [Body Part, Organ, or Organ Component]
   714   C0007776:Cortex [Body Part, Organ, or Organ Component]
   714   C1176472:Cortex [Body Part, Organ, or Organ Component]
   714   C2700441:Cortex [Plant]

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a copy of the K variant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1948062:Copy [Manufactured Object]
Processing 00000000.tx.13: We found no difference in plaque or tangle load between these two groups in either the total, late-onset or early-onset AD subjects. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no difference in plaque"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "tangle load between these two groups"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1550025:Load [Idea or Concept]
   753   C1704782:Load [Manufactured Object]
   753   C1708715:Load [Activity]

Phrase: "in either"

Phrase: "the total,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "or"

Phrase: "early-onset AD subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]
Processing 00000000.tx.14: Stratification of the total AD group in terms of APO E [epsis]4 allele possession, and further comparison of plaque and tangle load between carriers and non-carriers of BCHE-K still failed to disclose a relationship between BCHE-K and AD. 

Phrase: "Stratification of the total AD group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514983:Stratification [Research Activity]

Phrase: "in terms of APO E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4 allele possession,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0871103:possession [Quantitative Concept]
   755 E C0850310:Possessed [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "further comparison of plaque"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "tangle load between carriers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1550025:Load [Idea or Concept]
   770   C1704782:Load [Manufactured Object]
   770   C1708715:Load [Activity]

Phrase: "and"

Phrase: "non-carriers of BCHE-K still"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007294:carriers [Finding]
   760   C1518422:Non [Functional Concept]
   726 E C0560175:Carrier [Finding]
   726 E C1706209:Carrier [Medical Device]
   726 E C3273162:Carrier [Intellectual Product]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disclose"

Phrase: "a relationship between BCHE-K"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "AD."
Processing 00000000.tx.15: We conclude that in the population studied here there is no association between BCHE-K and AD, or that if such a relationship exists it is precluded by another, as yet unknown factor. 

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that in the population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "here there"

Phrase: "is"

Phrase: "no association between BCHE-K"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "AD,"

Phrase: "or"

Phrase: "that"

Phrase: "if"

Phrase: "such a relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439849:Relationship [Qualitative Concept]
  1000   C1705630:Relationship [Idea or Concept]
  1000   C1706279:Relationship [Idea or Concept]
  1000   C3540605:Relationship [Intellectual Product]

Phrase: "exists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "it"

Phrase: "is"

Phrase: "precluded by another,"

Phrase: "as yet unknown factor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439673:Unknown [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.16: INTRODUCTION Alzheimer's disease (AD) is an insidiously progressive dementia, primarily affecting the elderly. 

Phrase: "INTRODUCTION Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "is"

Phrase: "an insidiously progressive dementia,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0743039:Dementia, progressive [Disease or Syndrome]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "primarily"

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the elderly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001792:Elderly [Population Group]
  1000   C1999167:elderly [Population Group]
Processing 00000000.tx.17: The disease is characterized clinically by gradual memory impairment and loss of pre-symptomatic persona leading ultimately to death. 

Phrase: "The disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "clinically by gradual memory impairment"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0233794:Memory impairment [Mental or Behavioral Dysfunction]
   806   C1963167:Memory impairment [Finding]
   760   C0025260:Memory [Mental Process]
   760   C0439833:Gradual [Qualitative Concept]
   760   C0684336:Impairment [Pathologic Function]
   760   C0700327:memory [Finding]
   760   C1706377:Memory [Manufactured Object]
   704 E C0679055:mnemonic [Mental Process]

Phrase: "and"

Phrase: "loss of pre-symptomatic persona"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "leading"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332152:Leading [Temporal Concept]
  1000   C1522538:Leading [Functional Concept]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "ultimately to death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011065:Death [Organism Function]
   790   C1306577:Death, NOS [Finding]
Processing 00000000.tx.18: The neuropathological hallmarks of the disease are primarily senile plaques (SPs) and neurofibrillary tangles (NFTs). 

Phrase: "The neuropathological hallmarks of the disease"

Phrase: "are"

Phrase: "primarily senile plaques (SPs)"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   827   C0392079:Senile [Finding]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   771 E C0231337:Old age [Finding]
   771 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "neurofibrillary tangles (NFTs)."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.19: AD is a genetically heterogeneous disorder with at least four genetic loci known at present (1-4). 

Phrase: "AD"

Phrase: "is"

Phrase: "a genetically heterogeneous disorder with"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1858576:Heterogeneous disorder [Finding]
   760   C0012634:Disorder [Disease or Syndrome]

Phrase: "at least four genetic loci"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   861   C0678933:Genetic Loci [Gene or Genome]
   812   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   812   C0314603:Genetic [Functional Concept]
   779   C1708726:Locus [Gene or Genome]
   756 E C0005615:Birth [Organism Function]
   756 E C0035150:Reproduction [Organism Function]
   756 E C0079946:origin [Classification]
   756 E C0439659:Origin [Temporal Concept]
   756 E C1550512:origin [Intellectual Product]
   756 E C1550722:birth [Idea or Concept]
   756 E C3245487:birth [Intellectual Product]
   729 E C0454729:Natal [Geographic Area]
   729 E C0559522:Genital [Body System]
   729 E C1546649:Genital [Intellectual Product]
   729 E C1550642:Genital [Body Substance]
   719 E C0205313:Original [Idea or Concept]
   719 E C2347409:Original [Occupational Activity]
   701 E C0598240:originality [Mental Process]

Phrase: "known at present"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C1444639:Known present [Qualitative Concept]
   790   C0150312:Present [Quantitative Concept]
   790   C0205309:Known [Qualitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "(1-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: Recently late-onset AD has also been suggested to be associated with a fifth locus, the K variant of the butyrylcholinesterase (BChE, plasma cholinesterase, acylcholine-acylhydrolase, EC 3.1.1.8) gene (5) situated on chromosome 3 (6). 

Phrase: "Recently late-onset AD"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with a fifth locus,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0205439:Fifth [Quantitative Concept]
   760   C1708726:Locus [Gene or Genome]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "the K variant of the butyrylcholinesterase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variant [Qualitative Concept]

Phrase: "(BChE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:BCHE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BCHE [Gene or Genome]

Phrase: "plasma cholinesterase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0728810:Plasma cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
           Cholinesterase
   861   C0008429:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "acylcholine-acylhydrolase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008429:Acylcholine acylhydrolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "EC 3.1.1.8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0030016:EC 1 [Amino Acid, Peptide, or Protein,Enzyme]
   853   C1417734:EC-1 [Gene or Genome]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "situated on chromosome 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0008666:Chromosome 3 [Cell Component]
   770   C0008633:Chromosome [Cell Component]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.21: Lehmann and colleagues have shown the K variant of BChE to be in excess in AD sufferers who carry the [epsis]4 allele of the apolipoprotein E gene (APO E) when compared with controls. 

Phrase: "Lehmann"

Phrase: "and"

Phrase: "colleagues"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the K variant of BChE to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variant [Qualitative Concept]

Phrase: "be in excess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1979886:Excess [Qualitative Concept]
   790   C2987476:Be [Conceptual Entity]

Phrase: "in AD sufferers"

Phrase: "who"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "the [epsis"

Phrase: "]4 allele of the apolipoprotein E gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   748   C0002085:Allele [Gene or Genome]
           allelic gene

Phrase: "(APO E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "when"

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.22: The function of BChE is, as yet, unknown; 

Phrase: "The function of BChE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: ","

Phrase: "as yet,"

Phrase: "unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.23: its activity, however, is known to increase with age and has been shown to be higher in AD cases (7,8). 

Phrase: "its activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "however,"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase with age"
Meta Candidates (Total=9; Excluded=7; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C0442805:Increase [Functional Concept]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "higher in AD cases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.24: There are at least seven genetic variants of the BChE gene (9-11), BCHE-K arising when there is a point mutation at nucleotide 1615. 

Phrase: "There"

Phrase: "are at least seven genetic variants of the BChE gene"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C1412756:BCHE gene [Gene or Genome]
           BCHE
   739   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   739   C0017337:Gene [Gene or Genome]
   739   C0205419:variants [Qualitative Concept]
   739   C0205453:Seven [Quantitative Concept]
   739   C0314603:Genetic [Functional Concept]
   739   C0728810:BCHE [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1551058:Are [Quantitative Concept]

Phrase: "(9-11"

Phrase: ")"

Phrase: ","

Phrase: "BCHE-K arising"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332284:arising [Qualitative Concept]

Phrase: "when"

Phrase: "there"

Phrase: "is"

Phrase: "a point mutation at nucleotide 1615."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   790   C2924612:A point [Body Location or Region]
   753   C0026882:Mutation [Genetic Function]
   753   C1552961:Point [Quantitative Concept]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
   753   C2347617:point [Quantitative Concept]
Processing 00000000.tx.25: Phenotypically, the K variant has been shown to cause a 30% reduction in BChE activity (12). 

Phrase: "Phenotypically,"

Phrase: "the K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a 30% reduction in BChE activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2267000:Reduction Activity [Molecular Function]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.26: Because of this putative association with AD, we have genotyped a large series of AD cases for the BCHE-K variant. 

Phrase: "Because of this putative association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "with AD,"

Phrase: "we"

Phrase: "have"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "a large series of AD cases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0150093:Case Series [Research Activity]
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "for the BCHE-K variant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.27: Additionally, we have attempted to define a biological effect of the BCHE-K variant by correlating BCHE-K genotypes with AD pathology. 

Phrase: "Additionally,"

Phrase: "we"

Phrase: "have"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "a biological effect of the BCHE-K variant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0005532:Biological [Biomedical Occupation or Discipline]
   748   C0205460:biological [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "by correlating BCHE-K genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]

Phrase: "with AD pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.28: RESULTS The results of the BChE genotyping are shown in Table 1. 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "The results of the BChE genotyping"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown in Table 1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.29: The population studied was found to be near or at Hardy-Weinberg equilibrium. 

Phrase: "The population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "near"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475806:Near [Finding]
  1000   C1706276:Near [Qualitative Concept]

Phrase: "or at Hardy-Weinberg equilibrium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014653:Equilibrium [Organism Function]
   760   C1547026:Equilibrium [Quantitative Concept]
Processing 00000000.tx.30: We found no significant difference in the frequency of the K variant between the three AD groups tested and age-matched control groups (total AD P = 0.43, early-onset AD P = 1, late-onset AD P = 0.53). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no significant difference in the frequency of the K variant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: "between the three AD groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "age-matched control groups"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   902   C0027362:Age Group [Age Group]
   902   C2348001:Age Group [Population Group]
   875   C0024908:Matched Group [Group]
   861   C0009932:Control Groups [Group]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "(total AD P = 0.43,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439175:% total [Quantitative Concept]
   804   C0439810:Total [Qualitative Concept]

Phrase: "early-onset AD P = 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1833334:Early-onset [Finding]
   804   C0332162:Onset [Qualitative Concept]
   804   C1279919:Early [Temporal Concept]

Phrase: "late-onset AD P = 0.53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0205087:Late [Temporal Concept]
   799   C0332162:Onset [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.31: These groups were then stratified according to APO E [epsis]4 allele frequency (Table 2) and compared with age-matched APO E [epsis]4 load-matched controls. 

Phrase: "These groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stratified according to APO E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205363:Stratified [Qualitative Concept]
   770   C0680240:according [Social Behavior]

Phrase: "[epsis"

Phrase: "]4 allele frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0017270:Allele Frequency [Quantitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "compared with age-matched APO E"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0001779:Age [Organism Attribute]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]

Phrase: "[epsis"

Phrase: "]4 load-matched controls."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0150103:matched [Research Activity]
   812   C1708943:Matched [Qualitative Concept]
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.32: No significant difference was found between any of these APO E [epsis]4 stratified AD groups and their respective control groups (Table 2). 

Phrase: "No significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "found between any of these APO E"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0150312:Found [Quantitative Concept]
   719 E C0243095:Find [Finding]

Phrase: "[epsis"

Phrase: "]4 stratified AD groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   902   C0441876:4 groups [Intellectual Product]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "their respective control groups"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   901   C0009932:Control Groups [Group]
   827   C0243148:control [Qualitative Concept]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1550141:Control [Substance]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.33: There was no difference in plaque or tangle density values in the frontal, temporal, parietal and occipital cortices between AD groups carrying and not carrying the BCHE-K genotype (total AD, plaque load DF3,341 F = 0.12, P = 0.95, tangle load DF3,337 F = 0.36, P = 0.78; late-onset AD, plaque load DF3,247 F = 0.41, P = 0.75, tangle load DF3,242 F = 0.74, P = 0.53; early-onset AD, plaque load DF3,80 F = 0.13, P = 0.95, tangle load DF3,79 F = 0.18, P = 0.91). 

Phrase: "There"

Phrase: "was"

Phrase: "no difference in plaque"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "tangle density values in the frontal, temporal, parietal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0042295:Values [Qualitative Concept]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "occipital cortices between AD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0028785:Occipital cortex [Body Part, Organ, or Organ Component]
   770   C1184145:Occipital [Body Location or Region]
   737   C0007776:Cortex [Body Part, Organ, or Organ Component]
   737   C1176472:Cortex [Body Part, Organ, or Organ Component]
   737   C2700441:Cortex [Plant]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the BCHE-K genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "(total AD,"

Phrase: "plaque load DF3,"

Phrase: "341 F = 0.12,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "P = 0.95,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "tangle load DF3,"

Phrase: "337 F = 0.36,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "P = 0.78"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; late-onset AD,"

Phrase: "plaque load DF3,"

Phrase: "247 F = 0.41,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "P = 0.75,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "tangle load DF3,"

Phrase: "242 F = 0.74,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "P = 0.53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; early-onset AD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1833334:Early-onset [Finding]

Phrase: "plaque load DF3,"

Phrase: "80 F = 0.13,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "P = 0.95,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "tangle load DF3,"

Phrase: "79 F = 0.18,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "P = 0.91"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.34: There was no significant difference in plaque or tangle load in the four cortical regions when comparing BCHE-K carriers with non-carriers in the total AD group stratified in terms of APO E [epsis]4 possession (APO E [epsis]4-negative cases, plaque load DF3,131 F = 0.37, P = 0.78, tangle load DF3,115 F = 0.29, P = 0.83; APO E [epsis]4-positive cases, plaque load DF3,205 F = 0.28, P = 0.84, tangle load DF3,214 F = 0.13, P = 0.94). 

Phrase: "There"

Phrase: "was"

Phrase: "no significant difference in plaque"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "tangle load in the four cortical regions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1550025:Load [Idea or Concept]
   748   C1704782:Load [Manufactured Object]
   748   C1708715:Load [Activity]

Phrase: "when"

Phrase: "comparing BCHE-K carriers with non-carriers"

Phrase: "in the total AD group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "stratified in terms of APO E"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205363:Stratified [Qualitative Concept]
   726   C1515273:Term [Temporal Concept]
   726   C1705313:Term [Idea or Concept]
   726   C2826302:TERM [Intellectual Product]

Phrase: "[epsis"

Phrase: "]4 possession"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0871103:possession [Quantitative Concept]
   789 E C0850310:Possessed [Mental or Behavioral Dysfunction]

Phrase: "(APO E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4-negative cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "plaque load DF3,"

Phrase: "131 F = 0.37,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "P = 0.78,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "tangle load DF3,"

Phrase: "115 F = 0.29,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "P = 0.83"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; APO E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4-positive cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "plaque load DF3,"

Phrase: "205 F = 0.28,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "P = 0.84,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "tangle load DF3,"

Phrase: "214 F = 0.13,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "P = 0.94"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.35: DISCUSSION One of the central findings in AD research is the reduction of the neurotransmitter acetylcholine and the dysfunction and loss of central cholinergic neurones from the basal forebrain (13). 

Phrase: "DISCUSSION One of the central findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "in AD research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "is"

Phrase: "the reduction of the neurotransmitter acetylcholine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0031847:dysfunction [Functional Concept]
  1000   C0277785:Dysfunction, NOS [Qualitative Concept]
   944 E C0231174:Malfunction [Functional Concept]
   944 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "loss of central cholinergic neurones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   809   C0598940:Loss of neurons [Finding]
   760   C1517945:Loss [Quantitative Concept]
   756   C1850496:Neuronal loss [Finding]

Phrase: "from the basal forebrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2331620:Basal forebrain [Body Part, Organ, or Organ Component]
   861   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]
   861   C0205112:Basal [Spatial Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.36: This loss of cholinergic transmission is thought to underlie some of the cognitive deficits observed in AD. 

Phrase: "This loss of cholinergic transmission"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "underlie"

Phrase: "some of the cognitive deficits"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   760   C0205392:Some [Quantitative Concept]
   760   C1516691:Cognitive [Functional Concept]
   760   C2987487:deficits [Qualitative Concept]
   760   C3540770:Some [Intellectual Product]
   726 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "observed in AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]
Processing 00000000.tx.37: The findings of Lehman and colleagues (5) which describe a genetic link between the cholinergic system and predisposition to AD therefore appeared promising. 

Phrase: "The findings of Lehman"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C2825141:Finding [Finding]

Phrase: "and"

Phrase: "colleagues"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "which"

Phrase: "describe"

Phrase: "a genetic link between the cholinergic system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1517892:Link [Intellectual Product]
   748   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "predisposition to AD therefore appeared promising."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0012655:Predisposition [Clinical Attribute]
   753   C0220898:Predisposition [Organism Attribute]
Processing 00000000.tx.38: It is difficult, however, to envisage a role for BCHE-K in the aetiology of AD. 

Phrase: "It"

Phrase: "is"

Phrase: "difficult, however,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "envisage"

Phrase: "a role for BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the aetiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "of AD."
Processing 00000000.tx.39: The BChE K variant has 30% less catalytic activity than normal butyrylcholinesterase (12) and would therefore be expected to lead to elevated levels of acetylcholine in the brains of AD patients. 

Phrase: "The BChE K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "has"

Phrase: "30% less catalytic activity than normal butyrylcholinesterase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0243102:catalytic activity [Molecular Function]
   778   C1264638:Catalytic activity [Functional Concept]
   778   C1547012:*Catalytic Activity [Quantitative Concept]
   774   C1149831:butyrylcholinesterase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "(12"

Phrase: ")"

Phrase: "and"

Phrase: "would"

Phrase: "therefore"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lead to elevated levels of acetylcholine"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   803   C1318746:Elevated lead level [Finding]
   783   C0428255:lead levels [Laboratory or Test Result]
   767 E C0524167:Lead level [Laboratory Procedure]
   753   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0205250:Elevated [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3163633:Elevated [Qualitative Concept]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of AD patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.40: Furthermore, there is an elevation of BChE activity in the AD brain which appears to be localized to SP, NFT and congophilic angiopathy (14,15). 

Phrase: "Furthermore,"

Phrase: "there"

Phrase: "is"

Phrase: "an elevation of BChE activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439775:Elevation [Therapeutic or Preventive Procedure]
   760   C0702240:Elevation [Spatial Concept]

Phrase: "in the AD brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "which"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "localized to SP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392752:Localized [Spatial Concept]

Phrase: "NFT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085400:NFT [Acquired Abnormality]

Phrase: "and"

Phrase: "congophilic angiopathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085220:Congophilic Angiopathy [Disease or Syndrome]
   861   C0042373:Angiopathy [Disease or Syndrome]

Phrase: "(14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.41: This would suggest that the BChE K variant would be less prevalent in AD, and not increased as Lehmann and colleagues suggest, or that there is a marked up-regulation of this variant in certain AD cases. 

Phrase: "This"

Phrase: "would"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the BChE K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "less prevalent in AD,"

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increased as Lehmann"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "colleagues"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: ","

Phrase: "or"

Phrase: "that there"

Phrase: "is"

Phrase: "a"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "up-regulation of this variant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041904:Up-Regulation [Cell Function,Molecular Function]
   806   C0162493:Up-Regulation [Genetic Function]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in certain AD cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.42: Table 1. 

Phrase: "Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.43: Distribution of the K variant in a population of AD patients and age-matched controls  Genotype Allele  G/G G/A A/A G A Total AD n = 119, mean age = 78.3  9.4 SD 82 (69) 34 (29) 3 (2) 198 (83) 40 (17) Total controls n = 83, mean age = 78.3  7.7 SD< 51 (62) 31 (37) 1 (1) 133 (80) 33 (20) EOAD n = 27, mean age=64.8  6.1 SD 20 (74) 7 (26) 0 (-) 47 (87) 7 (13) Young controls n = 50, mean age = 64.3  5.8 SD 38 (76) 11 (22) 1 (2) 87 (87) 13 (13) LOAD n = 92, mean age = 82.6  5.3 SD 62 (68) 27 (29) 3 (3) 151 (82) 33 (18) Aged controls n = 70, mean age = 80.1  7.1 SD 42 (60) 27 (39) 1 (1) 111 (79) 29 (21) The numbers in parentheses represent genotype or allele frequencies. 

Phrase: "Distribution of the K variant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "in a population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "of AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "age-matched controls  Genotype Allele  G/G G/A A/A G"

Phrase: "A Total AD n = 119,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439175:% total [Quantitative Concept]
   812   C0439810:Total [Qualitative Concept]

Phrase: "mean age = 78.3  9.4 SD 82"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0001779:Age [Organism Attribute]
   793   C0444504:Mean [Quantitative Concept]
   793   C2347634:Mean [Quantitative Concept]
   793   C2348143:Mean [Quantitative Concept]

Phrase: "(69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")"

Phrase: "34"

Phrase: "(29"

Phrase: ")"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "198"

Phrase: "(83"

Phrase: ")"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "(17"

Phrase: ")"

Phrase: "Total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "n = 83,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "mean age = 78.3  7.7 SD< 51"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0001779:Age [Organism Attribute]
   793   C0444504:Mean [Quantitative Concept]
   793   C2347634:Mean [Quantitative Concept]
   793   C2348143:Mean [Quantitative Concept]

Phrase: "(62"

Phrase: ")"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "(37"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "133"

Phrase: "(80"

Phrase: ")"

Phrase: "33"

Phrase: "(20"

Phrase: ")"

Phrase: "EOAD n = 27,"

Phrase: "mean age=64.8  6.1 SD 20"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0001779:Age [Organism Attribute]
   793   C0444504:Mean [Quantitative Concept]
   793   C2347634:Mean [Quantitative Concept]
   793   C2348143:Mean [Quantitative Concept]

Phrase: "(74"

Phrase: ")"

Phrase: "7"

Phrase: "(26"

Phrase: ")"

Phrase: "0"

Phrase: "(-"

Phrase: ")"

Phrase: "47"

Phrase: "(87"

Phrase: ")"

Phrase: "7"

Phrase: "(13"

Phrase: ")"

Phrase: "Young controls n = 50,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0332239:Young [Temporal Concept]
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]

Phrase: "mean age = 64.3  5.8 SD 38"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0001779:Age [Organism Attribute]
   793   C0444504:Mean [Quantitative Concept]
   793   C2347634:Mean [Quantitative Concept]
   793   C2348143:Mean [Quantitative Concept]

Phrase: "(76"

Phrase: ")"

Phrase: "11"

Phrase: "(22"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "87"

Phrase: "(87"

Phrase: ")"

Phrase: "13"

Phrase: "(13"

Phrase: ")"

Phrase: "LOAD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "n = 92,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "mean age = 82.6  5.3 SD 62"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0650999:SD 62 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   793   C0001779:Age [Organism Attribute]
   793   C0444504:Mean [Quantitative Concept]
   793   C2347634:Mean [Quantitative Concept]
   793   C2348143:Mean [Quantitative Concept]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")"

Phrase: "27"

Phrase: "(29"

Phrase: ")"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "151"

Phrase: "(82"

Phrase: ")"

Phrase: "33"

Phrase: "(18"

Phrase: ")"

Phrase: "Aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "n = 70,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "mean age = 80.1  7.1 SD 42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0001779:Age [Organism Attribute]
   793   C0444504:Mean [Quantitative Concept]
   793   C2347634:Mean [Quantitative Concept]
   793   C2348143:Mean [Quantitative Concept]

Phrase: "(60"

Phrase: ")"

Phrase: "27"

Phrase: "(39"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "111"

Phrase: "(79"

Phrase: ")"

Phrase: "29"

Phrase: "(21"

Phrase: ")"

Phrase: "The numbers in parentheses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "or"

Phrase: "allele frequencies."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0017270:Frequencies, Allele [Quantitative Concept]
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]
Processing 00000000.tx.44: EOAD, early-onset Alzheimer's disease; 

Phrase: "EOAD,"

Phrase: "early-onset Alzheimer's disease"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.45: LOAD, late-onset Alzheimer's disease. 

Phrase: "LOAD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "late-onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.46: Table 2. 

Phrase: "Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.47: BChE genotypes of groups when stratified according to APO E [epsis]4 allele load Group APO E N Genotype Allele P-valuea  [epsis]4  GG GA AA G A  Total AD 0 41 29 (71) 11 (27) 1 (2) 69 (84) 13 (16) 0.77  1 56 37 (66) 17 (30) 2 (4) 91 (81) 21 (19) 0.18  2b 22 16 (73) 6 (27) 0 (-) 38 (86) 6 (14) 0.09 Controls 0 66 43 (65) 23 (35) 0 (-) 109 (83) 23 (17)   1 17 8 (47) 8 (47) 1 (6) 24 (71) 10 (29)  EOAD 0 11 8 (73) 3 (27) 0 (-) 19 (86) 3 (14) 0.99  1 10 7 (70) 3 (30) 0 (-) 17 (85) 3 (15) 0.73  2b 6 5 (83) 1 (17) 0 (-) 11 (92) 1 (8) 0.77 Controls 0 37 27 (73) 10 (27) 0 (-) 64 (86) 10 (14)   1 13 11 (84) 1 (8) 1 (8) 23 (88) 2 (12)  LOAD 0 30 21 (70) 8 (27) 1 (3) 50 (83) 10 (17) 0.80  1 46 30 (65) 14 (31) 2 (4) 74 (80) 18 (20) 0.23  2b 16 11 (69) 5 (31) 0 (-) 27 (84) 5 (16) 0.18 Controls 0 55 35 (64) 20 (36) 0 (-) 90 (82) 20 (18)   1 15 7 (47) 7 (47) 1 (6) 21 (70) 9 (30)  EOAD, early-onset Alzheimer's disease; 

Phrase: "BChE genotypes of groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017431:Genotypes [Organism Attribute]

Phrase: "when"

Phrase: "stratified according to APO E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205363:Stratified [Qualitative Concept]
   770   C0680240:according [Social Behavior]

Phrase: "[epsis"

Phrase: "]4 allele load Group APO E N Genotype Allele P-valuea"

Phrase: "[epsis"

Phrase: "]4  GG GA AA G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439267:g% [Quantitative Concept]

Phrase: "A  Total AD 0 41 29"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0101467:AD 41 [Organic Chemical]
   804   C0439175:% total [Quantitative Concept]
   804   C0439810:Total [Qualitative Concept]

Phrase: "(71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")"

Phrase: "11"

Phrase: "(27"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "(84"

Phrase: ")"

Phrase: "13"

Phrase: "(16"

Phrase: ")"

Phrase: "0.77  1 56 37"

Phrase: "(66"

Phrase: ")"

Phrase: "17"

Phrase: "(30"

Phrase: ")"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(4"

Phrase: ")"

Phrase: "91"

Phrase: "(81"

Phrase: ")"

Phrase: "21"

Phrase: "(19"

Phrase: ")"

Phrase: "0.18  2b 22 16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0450334:18/22 [Quantitative Concept]
   804   C0450354:2b [Intellectual Product]
   804   C1706096:2B [Research Activity]

Phrase: "(73"

Phrase: ")"

Phrase: "6"

Phrase: "(27"

Phrase: ")"

Phrase: "0"

Phrase: "(-"

Phrase: ")"

Phrase: "38"

Phrase: "(86"

Phrase: ")"

Phrase: "6"

Phrase: "(14"

Phrase: ")"

Phrase: "0.09 Controls 0 66 43"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   766   C0243148:control [Qualitative Concept]
   766   C1550141:Control [Substance]
   766   C1882979:Control [Conceptual Entity]
   766   C2587213:Control [Functional Concept]
   766   C3274648:Control [Qualitative Concept]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "(35"

Phrase: ")"

Phrase: "0"

Phrase: "(-"

Phrase: ")"

Phrase: "109"

Phrase: "(83"

Phrase: ")"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "(17"

Phrase: ")"

Phrase: "1 17 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "(47"

Phrase: ")"

Phrase: "8"

Phrase: "(47"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(6"

Phrase: ")"

Phrase: "24"

Phrase: "(71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")"

Phrase: "10"

Phrase: "(29"

Phrase: ")"

Phrase: "EOAD 0 11 8"

Phrase: "(73"

Phrase: ")"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(27"

Phrase: ")"

Phrase: "0"

Phrase: "(-"

Phrase: ")"

Phrase: "19"

Phrase: "(86"

Phrase: ")"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(14"

Phrase: ")"

Phrase: "0.99  1 10 7"

Phrase: "(70"

Phrase: ")"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(30"

Phrase: ")"

Phrase: "0"

Phrase: "(-"

Phrase: ")"

Phrase: "17"

Phrase: "(85"

Phrase: ")"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(15"

Phrase: ")"

Phrase: "0.73  2b 6 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   897   C0444499:0/5 [Quantitative Concept]
   804   C0450354:2b [Intellectual Product]
   804   C1706096:2B [Research Activity]

Phrase: "(83"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(17"

Phrase: ")"

Phrase: "0"

Phrase: "(-"

Phrase: ")"

Phrase: "11"

Phrase: "(92"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(8"

Phrase: ")"

Phrase: "0.77 Controls 0 37 27"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   766   C0243148:control [Qualitative Concept]
   766   C1550141:Control [Substance]
   766   C1882979:Control [Conceptual Entity]
   766   C2587213:Control [Functional Concept]
   766   C3274648:Control [Qualitative Concept]

Phrase: "(73"

Phrase: ")"

Phrase: "10"

Phrase: "(27"

Phrase: ")"

Phrase: "0"

Phrase: "(-"

Phrase: ")"

Phrase: "64"

Phrase: "(86"

Phrase: ")"

Phrase: "10"

Phrase: "(14"

Phrase: ")"

Phrase: "1 13 11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "(84"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(8"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(8"

Phrase: ")"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "(88"

Phrase: ")"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(12"

Phrase: ")"

Phrase: "LOAD 0 30 21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1550025:Load [Idea or Concept]
   812   C1704782:Load [Manufactured Object]
   812   C1708715:Load [Activity]

Phrase: "(70"

Phrase: ")"

Phrase: "8"

Phrase: "(27"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "50"

Phrase: "(83"

Phrase: ")"

Phrase: "10"

Phrase: "(17"

Phrase: ")"

Phrase: "0.80  1 46 30"

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: "14"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(4"

Phrase: ")"

Phrase: "74"

Phrase: "(80"

Phrase: ")"

Phrase: "18"

Phrase: "(20"

Phrase: ")"

Phrase: "0.23  2b 16 11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0450348:23 [Quantitative Concept]
   804   C0450354:2b [Intellectual Product]
   804   C1706096:2B [Research Activity]

Phrase: "(69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "0"

Phrase: "(-"

Phrase: ")"

Phrase: "27"

Phrase: "(84"

Phrase: ")"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(16"

Phrase: ")"

Phrase: "0.18 Controls 0 55 35"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0450382:55 [Intellectual Product]
   766   C0243148:control [Qualitative Concept]
   766   C1550141:Control [Substance]
   766   C1882979:Control [Conceptual Entity]
   766   C2587213:Control [Functional Concept]
   766   C3274648:Control [Qualitative Concept]

Phrase: "(64"

Phrase: ")"

Phrase: "20"

Phrase: "(36"

Phrase: ")"

Phrase: "0"

Phrase: "(-"

Phrase: ")"

Phrase: "90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "(82"

Phrase: ")"

Phrase: "20"

Phrase: "(18"

Phrase: ")"

Phrase: "1 15 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C3541329:1-7 [Gene or Genome]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "(47"

Phrase: ")"

Phrase: "7"

Phrase: "(47"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(6"

Phrase: ")"

Phrase: "21"

Phrase: "(70"

Phrase: ")"

Phrase: "9"

Phrase: "(30"

Phrase: ")"

Phrase: "EOAD,"

Phrase: "early-onset Alzheimer's disease"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.48: LOAD, late-onset Alzheimer's disease. 

Phrase: "LOAD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "late-onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.49: Note: all control groups are age-matched. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: ":"

Phrase: "all control groups"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0009932:Control Groups [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "are"

Phrase: "age-matched."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0001779:Age [Organism Attribute]
   861   C0150103:matched [Research Activity]
   861   C1708943:Matched [Qualitative Concept]
Processing 00000000.tx.50: aP-value of [chi]2 tests comparing each AD group with an age-matched genotype-matched control group. 

Phrase: "aP-value of [chi]2 tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0022885:Tests [Laboratory Procedure]
   799   C0392366:Tests [Intellectual Product]
   766 E C0039593:Test [Functional Concept]

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "each AD group with an age-matched genotype-matched control group."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0009932:Control Group [Group]
Processing 00000000.tx.51: bThe APO E [epsis]4/4 AD groups were compared with control cases with one [epsis]4 allele. 

Phrase: "bThe APO E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4/4 AD groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   902   C0441876:4 groups [Intellectual Product]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "compared with control cases"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   802   C0872128:case control [Health Care Activity]
   770   C0243148:control [Qualitative Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "with one [epsis"

Phrase: "]4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.52: There are a number of possibilities as to why our study has failed to find an association between BCHE-K and AD. 

Phrase: "There"

Phrase: "are"

Phrase: "a number of possibilities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "as to why"

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "an association between BCHE-K"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "AD."
Processing 00000000.tx.53: One possibility is that there is another stronger genetic influence on late-onset AD acting in concert with the APO E [epsis]4 allele which precludes the effect of BCHE-K. 

Phrase: "One possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that there"

Phrase: "is"

Phrase: "another stronger genetic influence on late-onset AD"

Phrase: "acting in concert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "with the APO E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "which"

Phrase: "precludes"

Phrase: "the effect of BCHE-K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.54: We have, however, previously studied the influence of presenilin-1, presenilin-2 and [alpha]-1-antichymotrypsin polymorphisms and failed to find any association with these loci (16,17); 

Phrase: "We"

Phrase: "have"

Phrase: ","

Phrase: "however,"

Phrase: "previously"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the influence of presenilin-1,"

Phrase: "presenilin-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and ["

Phrase: "alpha]-1-antichymotrypsin polymorphisms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]
   756   C0002190:alpha 1-Antichymotrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412050:ANTICHYMOTRYPSIN, ALPHA-1 [Gene or Genome]

Phrase: "and"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "any association with these loci"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "(16,"

Phrase: "17"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.55: this does not, however, negate the possibility that another as yet unidentified locus is exerting an effect. 

Phrase: "this"

Phrase: "does"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "however,"

Phrase: "negate"

Phrase: "the possibility"

Phrase: "that"

Phrase: "another as yet unidentified locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205427:Unidentified [Qualitative Concept]
   760   C1708726:Locus [Gene or Genome]

Phrase: "is"

Phrase: "exerting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exerting [Organism Function]

Phrase: "an effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.56: The BCHE-K locus itself may be in linkage disequilibrium with an as yet unidentified gene that has an effect in AD. 

Phrase: "The BCHE-K locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "itself"

Phrase: "may"

Phrase: "be in linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C2987476:Be [Conceptual Entity]

Phrase: "with an as yet unidentified gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1442846:AS gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "that"

Phrase: "has"

Phrase: "an effect in AD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1883473:Ad Effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.57: If this is the case, then it is conceivable that in the population which is studied here, which is relatively conserved, these two loci are not in disequilibrium and hence the BCHE-K locus would be unrelated to AD. 

Phrase: "If"

Phrase: "this"

Phrase: "is"

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "it"

Phrase: "is"

Phrase: "conceivable"

Phrase: "that in the population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "which"

Phrase: "is"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "here,"

Phrase: "which"

Phrase: "is"

Phrase: "relatively"

Phrase: "conserved"

Phrase: ","

Phrase: "these two loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "are"

Phrase: "not in disequilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0281825:Disequilibrium [Finding]
   790   C0394006:Disequilibrium [Disease or Syndrome]
   790   C1518422:Not [Functional Concept]

Phrase: "and"

Phrase: "hence"

Phrase: "the BCHE-K locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "would"

Phrase: "be"

Phrase: "unrelated to AD."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0445356:Unrelated [Finding]
   790   C1704623:Unrelated [Qualitative Concept]
   718 E C0680208:unrelatedness [Social Behavior]
Processing 00000000.tx.58: The finding of evidence for genetic loci on chromosomes 4, 6, 12 and 20 associated with AD (18) would suggest possible confounding factors in any such studies for disease association, and any results should only be explored further if such candidate genes are taken into account in the analysis. 

Phrase: "The finding of evidence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C2825141:Finding [Finding]

Phrase: "for genetic loci"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
  1000   C0678933:Genetic Loci [Gene or Genome]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1708726:Locus [Gene or Genome]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "on chromosomes 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0008667:Chromosome 4 [Cell Component]
   861   C0008633:Chromosomes [Cell Component]

Phrase: "6,"

Phrase: "12"

Phrase: "and"

Phrase: "20"

Phrase: "associated with AD (18"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")"

Phrase: "would"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "possible confounding factors in any"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "such"

Phrase: "studies for disease association,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C1511978:Disease Association [Temporal Concept]
   770   C0004083:Association [Mental Process]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0439849:Association [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "any results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "should"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "be"

Phrase: "explored"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "if"

Phrase: "such candidate genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1332838:Candidate Genes [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "taken into account"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1551359:account [Idea or Concept]
   790   C1883727:Taken [Conceptual Entity]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]
   756 E C1515187:Take [Health Care Activity]

Phrase: "in the analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]
Processing 00000000.tx.59: MATERIALS AND METHODS All cases of AD and controls were from a large prospective clinico-pathological study in the North East of England. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "All cases of AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "were from a large prospective clinico-pathological study"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0033522:prospective study [Research Activity]
   767   C1709709:Prospective Study [Research Activity]
   744   C0023981:prospective [Research Activity]
   744   C0030664:Pathological [Biomedical Occupation or Discipline]
   744   C0549177:Large [Quantitative Concept]
   744   C0557651:Study [Manufactured Object]
   744   C1521733:Pathological [Functional Concept]
   744   C2603343:Study [Research Activity]
   735   C0551718:Pathology study [Clinical Attribute]

Phrase: "in the North East"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1707877:East [Spatial Concept]
   861   C1709269:North [Spatial Concept]

Phrase: "of England."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014282:England [Geographic Area]
Processing 00000000.tx.60: AD cases were clinically diagnosed as such and after death confirmed neuropathologically. 

Phrase: "AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "clinically"

Phrase: "diagnosed as such"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0011900:Diagnosed [Finding]

Phrase: "and after death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011065:Death [Organism Function]
   790   C1306577:Death, NOS [Finding]
   790   C1515981:And [Idea or Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "neuropathologically."
Processing 00000000.tx.61: Cases with any other significant neuropathology were excluded. 

Phrase: "Cases with any"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0868928:Cases [Functional Concept]
   790   C1533148:Cases [Quantitative Concept]
   756 E C1706255:CASE [Medical Device]
   756 E C1706256:Case [Conceptual Entity]

Phrase: "other significant neuropathology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   861   C1540677:neuropathology [Pathologic Function]
   861   C1555824:Neuropathology [Intellectual Product]

Phrase: "were"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.62: Control cases were identified as being free of any neuropsychiatric disease and at post-mortem were found to have age-associated neuropathological abnormalities only. 

Phrase: "Control cases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0243148:control [Qualitative Concept]
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "as"

Phrase: "being"

Phrase: "free of any neuropsychiatric disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332296:free [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "and at post-mortem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0004398:postmortem [Diagnostic Procedure]
   833   C0580205:Postmortem [Temporal Concept]
   833   C0848632:post mortem [Finding]
   770   C0687676:Post [Temporal Concept]
   770   C1515981:And [Idea or Concept]
   770   C1704687:Post [Manufactured Object]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "age-associated neuropathological abnormalities only."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   804   C0000768:Abnormalities [Congenital Abnormality]
   804   C0000769:abnormalities [Functional Concept]
   771 E C1704258:Abnormality [Finding]
   721 E C0205161:Abnormal [Qualitative Concept]
   721 E C2347472:% Abnormal [Quantitative Concept]
   721 E C2699333:ABNORMAL [Intellectual Product]
Processing 00000000.tx.63: Genomic DNA was isolated from 250-300 mg of brain tissue by standard proteinase K digestion and phenol-chloroform extraction. 

Phrase: "Genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "isolated from 250-300 mg of brain tissue"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   770   C0440746:Brain tissue [Tissue]
   770   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0040300:Tissue [Tissue]
   744   C0205409:Isolated [Functional Concept]
   744   C0439269:mg% [Quantitative Concept]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1547928:Tissue [Intellectual Product]
   744   C1548221:Isolated [Idea or Concept]
   744   C1960952:mg % [Quantitative Concept]
   744   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "by standard proteinase K digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0012238:Digestion [Organism Function]
   812   C2349986:Digestion [Research Activity]
   756 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "phenol-chloroform extraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185115:Extraction [Therapeutic or Preventive Procedure]
   827   C0684295:extraction [Laboratory Procedure]
Processing 00000000.tx.64: PCR amplification was performed using mismatch oligonucleotide primers previously described (6), forward 5[prime]ATATTTTACAGGAAATATTGATGTA 3[prime] (mismatch underlined), reverse 5[prime]ATTAGAGACCCACACAACTT 3[prime]. 

Phrase: "PCR amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mismatch oligonucleotide primers previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206415:Oligonucleotide Primers [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]ATATTTTACAGGAAATATTGATGTA 3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "(mismatch underlined"

Phrase: ")"

Phrase: ","

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]ATTAGAGACCCACACAACTT 3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]."
Processing 00000000.tx.65: Reaction conditions were: 94C for 1 min followed by 35 cycles of 53C for 20 s, 72C for 20 s and 94C for 20 s. 

Phrase: "Reaction conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: ":"

Phrase: "94C for 1 min"

Phrase: "followed by 35 cycles of 53C"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332283:Followed by [Temporal Concept]
           followed
   719   C1511572:Cycle [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "for 20 s,"

Phrase: "72C for 20 s"

Phrase: "and"

Phrase: "94C for 20 s."
Processing 00000000.tx.66: The resulting fragment was digested with the restriction endonuclease MaeIII and electrophoresed on a 3% agarose (2% NuSeive GTG agarose, 1% NuSeive LE agarose; Flowgen, UK) gel containing ethidium bromide and viewed via UV transillumination. 

Phrase: "The resulting fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "digested with the restriction endonuclease MaeIII"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0012906:Restriction Endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0059186:MaeIII endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0014230:endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0443288:Restriction [Functional Concept]
   753   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "electrophoresed on a 3% agarose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036681:Agarose [Carbohydrate]
   726   C0013855:electrophorese [Laboratory Procedure]

Phrase: "(2% NuSeive GTG agarose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036681:Agarose [Carbohydrate]

Phrase: "1% NuSeive LE agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036681:Agarose [Carbohydrate]

Phrase: "; Flowgen,"

Phrase: "UK"

Phrase: ")"

Phrase: "gel containing ethidium bromide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   812   C0006222:Bromide [Inorganic Chemical]
   812   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "viewed via UV transillumination."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0040706:Transillumination [Diagnostic Procedure]
   770   C0041625:UV [Natural Phenomenon or Process]
   770   C1961129:uV [Quantitative Concept]
   737   C0449911:View [Spatial Concept]
Processing 00000000.tx.67: The presence of a BCHE-K allele is indicated by a band at 115 bp and a non-K allele by a band at 137 bp. 

Phrase: "The presence of a BCHE-K allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "indicated by a band"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0230715:A band [Cell Component]
   770   C0175723:Band [Medical Device]
   770   C0439645:Band [Spatial Concept]
   770   C1444656:Indicated [Finding]
   770   C1521913:band [Cell Component]

Phrase: "at 115 bp"

Phrase: "and"

Phrase: "a non-K allele by a band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Allele [Gene or Genome]

Phrase: "at 137 bp."
Processing 00000000.tx.68: APO E genotyping was performed as previously described (19). 

Phrase: "APO E genotyping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285573:Genotyping [Laboratory Procedure]

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.69: The chi-squared ([chi]2) test was used to analyse data for any significant change in the frequency of the K variant and K variant homozygosity when compared with age-matched controls. 

Phrase: "The chi-squared"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1552646:chi square [Quantitative Concept]
   861   C1720589:Chi [Intellectual Product]
   827   C0205120:Square [Spatial Concept]
   827   C1552595:Square [Intellectual Product]

Phrase: "("

Phrase: "[chi]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1720589:Chi [Intellectual Product]

Phrase: ")"

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyse"

Phrase: "data for any significant change"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "in the frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "of the K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "and"

Phrase: "K variant homozygosity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019904:Homozygosity [Organism Attribute]

Phrase: "when"

Phrase: "compared with age-matched controls."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.70: Significance was adjudged to be reached at the 1% level. 

Phrase: "Significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "adjudged"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "reached at the 1% level."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0456947:Level 1 [Intellectual Product]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]
   726   C2584321:Reach [Organism Function]
Processing 00000000.tx.71: Tissue blocks from the frontal, temporal, parietal and occipital cortices were embedded in paraffin wax and 10 m sections were stained with von Braunmuhls method and Palmgrens silver method (20) respectively for SP and NFT. 

Phrase: "Tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "blocks from the frontal, temporal, parietal"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0028778:Block [Pathologic Function]
   753   C0205123:Frontal [Spatial Concept]
   753   C0332206:Block [Functional Concept]
   753   C0442030:Parietal [Spatial Concept]
   753   C0442043:Temporal [Spatial Concept]
   753   C1533157:Block [Substance]
   753   C1706084:Block [Geographic Area]
   753   C2362314:Temporal [Temporal Concept]
   753   C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "occipital cortices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0028785:Occipital cortex [Body Part, Organ, or Organ Component]
   861   C1184145:Occipital [Body Location or Region]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "were"

Phrase: "embedded in paraffin wax"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0030415:Paraffin wax [Biomedical or Dental Material,Lipid]
           Paraffin
   819   C0085185:embedded paraffin [Laboratory Procedure]
   770   C0043076:wax [Biologically Active Substance,Biomedical or Dental Material,Lipid]
   770   C0740486:Wax [Body Substance]
   770   C1707903:Embedded [Laboratory Procedure]

Phrase: "and"

Phrase: "10 m sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained with von Braunmuhls method"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   781   C0487602:Stain method [Laboratory Procedure]
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "Palmgrens silver method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "(20"

Phrase: ")"

Phrase: "respectively for SP"

Phrase: "and"

Phrase: "NFT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085400:NFT [Acquired Abnormality]
Processing 00000000.tx.72: Mean neocortical SP and NFT counts were determined by counting five fields defined by a strip running from the pial surface to the grey-white interface. 

Phrase: "Mean neocortical SP"

Phrase: "and"

Phrase: "NFT counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439157:counts [Quantitative Concept]
   827 E C0750480:Count [Activity]
   827 E C1705566:Count [Quantitative Concept]

Phrase: "were"

Phrase: "determined by counting five fields"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205451:Five [Quantitative Concept]
   726   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   726   C0750480:Count [Activity]
   726   C1521738:Field [Conceptual Entity]
   726   C1705566:Count [Quantitative Concept]
   726   C2346620:Field [Conceptual Entity]
   726   C2349184:Field [Conceptual Entity]
   726   C3539073:FIELD [Spatial Concept]

Phrase: "defined by a strip running"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0035953:Running [Daily or Recreational Activity]
   760   C1321564:Strip [Medical Device]
   760   C1704788:Defined [Conceptual Entity]
   760   C2346414:Running [Finding]
   760   C3539106:Defined [Intellectual Product]

Phrase: "from the pial surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205148:Surface [Spatial Concept]

Phrase: "to the grey-white interface."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007457:White [Population Group]
   827   C0043157:White [Population Group]
   827   C0220938:White [Qualitative Concept]
   827   C0556636:gray [Quantitative Concept]
   827   C1269776:Gray [Qualitative Concept]
   827   C1708533:Interface [Manufactured Object]
   827   C2698172:Interface [Intellectual Product]
Processing 00000000.tx.73: The resultant count/mm2 was averaged for each lobe. 

Phrase: "The resultant count/mm2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0456786:mm2 [Quantitative Concept]

Phrase: "was"

Phrase: "averaged for each lobe."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0796494:lobe [Body Part, Organ, or Organ Component]
   770   C1428707:Lobe [Gene or Genome]
   770   C3539671:Lobe [Gene or Genome]
   737   C1510992:Average [Quantitative Concept]
   737   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.74: SP and NFT densities for the four cortical areas were compared between carriers and non-carriers of BCHE-K in total, late-onset and early-onset AD groups using a general linear model. 

Phrase: "SP"

Phrase: "and"

Phrase: "NFT densities for the four cortical areas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0178587:densities [Quantitative Concept]

Phrase: "were"

Phrase: "compared between carriers"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007294:carriers [Finding]
   790   C1707455:Compared [Activity]
   756 E C0560175:Carrier [Finding]
   756 E C1706209:Carrier [Medical Device]
   756 E C3273162:Carrier [Intellectual Product]

Phrase: "and"

Phrase: "non-carriers of BCHE-K"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007294:carriers [Finding]
   770   C1518422:Non [Functional Concept]
   737 E C0560175:Carrier [Finding]
   737 E C1706209:Carrier [Medical Device]
   737 E C3273162:Carrier [Intellectual Product]

Phrase: "in total,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "early-onset AD groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a general linear model."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0023732:Model, Linear [Quantitative Concept]
   827   C0205132:Linear [Spatial Concept]
   827   C0205246:General [Spatial Concept]
   827   C1553889:General [Idea or Concept]
   827   C3161035:Model [Intellectual Product]
Processing 00000000.tx.75: Groups were also stratified according to APO E genotype and BCHE-K variant genotype. 

Phrase: "Groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "also"

Phrase: "stratified according to APO E genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017431:Genotype [Organism Attribute]
   760   C0205363:Stratified [Qualitative Concept]
   760   C0680240:according [Social Behavior]

Phrase: "and"

Phrase: "BCHE-K variant genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.76: Significance was adjudged to be at the 5% level. 

Phrase: "Significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "adjudged"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be at the 5% level."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0456951:Level 5 [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]
   760   C2987476:Be [Conceptual Entity]
Processing 00000000.tx.77: ACKNOWLEDGEMENT This work was supported, in part, by the States Education Council, Guernsey. 

Phrase: "ACKNOWLEDGEMENT"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by the States Education Council,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551807:Council [Population Group]

Phrase: "Guernsey."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018370:Guernsey [Geographic Area]
Processing 00000000.tx.78: REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.79: Hardy, J. 

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.80: (1997) Amyloid, the presenilins and Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.81: Trends Neurosci., 20, 154-159. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci.,"

Phrase: "20,"

Phrase: "154-159."
Processing 00000000.tx.82: MEDLINE Abstract 2. 

Phrase: "MEDLINE Abstract 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.83: Alzheimer's Disease Research Group (1995) The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. 

Phrase: "Alzheimer's Disease Research Group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "(1995"

Phrase: ")"

Phrase: "The structure of the presenilin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "(S182"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418985:S182 [Gene or Genome]
  1000   C2986918:S182 [Gene or Genome]

Phrase: ")"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "identification of six novel mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in early onset AD families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.84: Nature, 11, 219-222. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "11,"

Phrase: "219-222."
Processing 00000000.tx.85: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.86: Rogaev, E.I., Sherrington, R., Rogaeva, E.A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T. et al). 

Phrase: "Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaeva,"

Phrase: "E.A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T. et al"

Phrase: ")."
Processing 00000000.tx.87: (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Familial Alzheimer's disease in kindreds"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "with missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008651:Chromosome 1 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "related to the Alzheimer's disease type 3 gene."
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   833   C1843013:Alzheimer disease type 3 [Disease or Syndrome]
           Alzheimer disease 3
   819   C2986918:Alzheimer Disease 3 Gene [Gene or Genome]
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C0441731:Type 3 [Classification]
   770   C0457464:disease type [Intellectual Product]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0314611:Gene type [Genetic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0017337:Gene [Gene or Genome]
   744   C0332307:Type [Qualitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1547052:*Type [Quantitative Concept]
   739   C0067430:MAL-3 [Organic Chemical]
   739   C1416989:MAL gene [Gene or Genome]
   739   C1425077:MALS-3 [Gene or Genome]
   711 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.88: Nature, 376, 775-778. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "376,"

Phrase: "775-778."
Processing 00000000.tx.89: MEDLINE Abstract 4. 

Phrase: "MEDLINE Abstract 4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.90: Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. 

Phrase: "Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Schmechel,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G.W., Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035853:Roses [Plant]
   793 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Haines,"

Phrase: "J.L."

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.91: (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Gene dose of apolipoprotein E type 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in late onset families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.92: Science, 261, 921-923. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "261,"

Phrase: "921-923."
Processing 00000000.tx.93: MEDLINE Abstract 5. 

Phrase: "MEDLINE Abstract 5."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.94: Lehmann, D.J., Johnston, C. and Smith, A.D. 

Phrase: "Lehmann,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Johnston,"

Phrase: "C."

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.95: (1997) Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Synergy between the genes"

Phrase: "for butyrylcholinesterase K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "and"

Phrase: "apolipoprotein E4 in late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.96: Hum. 

Phrase: "Hum."
Processing 00000000.tx.97: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.98: Genet., 6, 1933-1936. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "6,"

Phrase: "1933-1936."
Processing 00000000.tx.99: MEDLINE Abstract 6. 

Phrase: "MEDLINE Abstract 6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.100: Jensen, F. 

Phrase: "Jensen,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.101: S., Nielsen, L.R. and Schwartz, M. 

Phrase: "S."

Phrase: ","

Phrase: "Nielsen,"

Phrase: "L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Schwartz,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.102: (1996) Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Detection of the plasma cholinesterase K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an amplification-created restriction site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1882940:Restriction Site [Nucleotide Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0443288:Restriction [Functional Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
Processing 00000000.tx.103: Hum. 

Phrase: "Hum."
Processing 00000000.tx.104: Hered., 46, 26-31. 

Phrase: "Hered.,"

Phrase: "46,"

Phrase: "26-31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]
Processing 00000000.tx.105: MEDLINE Abstract 7. 

Phrase: "MEDLINE Abstract 7."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.106: Perry, E.K., Perry, R.H., Blessed, G. and Tomlinson, B.E. 

Phrase: "Perry,"

Phrase: "E.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Perry,"

Phrase: "R.H.,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Blessed,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Tomlinson,"

Phrase: "B.E."
Processing 00000000.tx.107: (1978) Changes in brain cholinesterases in senile dementia of the Alzheimer type. 

Phrase: "(1978"

Phrase: ")"

Phrase: "Changes in brain cholinesterases"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0008429:Cholinesterases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1705241:Change [Quantitative Concept]
   737 E C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   737 E C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in senile dementia"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0002395:Dementia, Senile [Disease or Syndrome]
  1000   C0011268:Senile dementia [Mental or Behavioral Dysfunction]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0392079:Senile [Finding]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "of the Alzheimer type."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.108: NeuroPath. 

Phrase: "NeuroPath."
Processing 00000000.tx.109: APP. 

Phrase: "APP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]
Processing 00000000.tx.110: Neurobiol., 4, 273-277. 

Phrase: "Neurobiol.,"

Phrase: "4,"

Phrase: "273-277."
Processing 00000000.tx.111: 8. 

Phrase: "8."
Processing 00000000.tx.112: Perry, E.K. 

Phrase: "Perry,"

Phrase: "E.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.113: (1980) The cholinergic system in old age and Alzheimer's disease. 

Phrase: "(1980"

Phrase: ")"

Phrase: "The cholinergic system in old age"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0684164:cholinergic system [Biologically Active Substance]
   753   C0449913:System [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.114: Age Ageing, 9, 1-8. 

Phrase: "Age Ageing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]

Phrase: "9,"

Phrase: "1-8."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.115: MEDLINE Abstract 9. 

Phrase: "MEDLINE Abstract 9."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.116: Whittaker, M. and Britten, J.J. 

Phrase: "Whittaker,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Britten,"

Phrase: "J.J."
Processing 00000000.tx.117: (1987) Eh, a new allele at cholinesterase locus 1. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Eh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520135:EH [Geographic Area]

Phrase: "a new allele at cholinesterase locus 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.118: Hum. 

Phrase: "Hum."
Processing 00000000.tx.119: Hered., 37, 54-58. 

Phrase: "Hered.,"

Phrase: "37,"

Phrase: "54-58."
Processing 00000000.tx.120: MEDLINE Abstract 10. 

Phrase: "MEDLINE Abstract 10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.121: Rubinstein, H.M., Dietz, A.A. and Lubrano, T. 

Phrase: "Rubinstein,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Dietz,"

Phrase: "A."

Phrase: "A."

Phrase: "and"

Phrase: "Lubrano,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.122: (1978) Ek, another quantitative variant at cholinesterase locus 1. 

Phrase: "(1978"

Phrase: ")"

Phrase: "Ek,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008415:EK [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "another quantitative variant at cholinesterase locus 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.123: J. 

Phrase: "J."
Processing 00000000.tx.124: Med. 

Phrase: "Med."
Processing 00000000.tx.125: Genet., 15, 27-29. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "15,"

Phrase: "27-29."
Processing 00000000.tx.126: MEDLINE Abstract 11. 

Phrase: "MEDLINE Abstract 11."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.127: Garry, P., Dietz, A.A., Lubrano, T., Ford, P.C., James, K. and Rubinstein, H.M. 

Phrase: "Garry,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Dietz,"

Phrase: "A."

Phrase: "A.,"

Phrase: "Lubrano,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ford,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "James,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rubinstein,"

Phrase: "H.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2348952:H/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.128: (1976) New allele at cholinesterse locus 1. 

Phrase: "(1976"

Phrase: ")"

Phrase: "New allele at cholinesterse locus 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.129: J. 

Phrase: "J."
Processing 00000000.tx.130: Med. 

Phrase: "Med."
Processing 00000000.tx.131: Genet., 13, 38-42. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "13,"

Phrase: "38-42."
Processing 00000000.tx.132: MEDLINE Abstract 12. 

Phrase: "MEDLINE Abstract 12."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.133: Bartels, C.F., Jensen, F.S., Lockridge, O., van der Spek, A.F.L., Rubinstein, H.M., Lubrano, T. and La Du, B.N. 

Phrase: "Bartels,"

Phrase: "C.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Jensen,"

Phrase: "F.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lockridge,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "van der Spek,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "A.F.L., Rubinstein,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Lubrano,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "La Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540681:DU [Idea or Concept]

Phrase: "B.N."
Processing 00000000.tx.134: (1992) DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. 

Phrase: "(1992"

Phrase: ")"

Phrase: "DNA mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with the human butyrylcholinesterase K-variant"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0086418:Human [Human]
   748   C0205419:Variant [Qualitative Concept]
   748   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]
   748   C1708601:K' [Quantitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "its linkage to the atypical variant mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0023745:linkage [Molecular Function]

Phrase: "and"

Phrase: "other polymorphic sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.135: Am. 

Phrase: "Am."
Processing 00000000.tx.136: J. 

Phrase: "J."
Processing 00000000.tx.137: Hum. 

Phrase: "Hum."
Processing 00000000.tx.138: Genet., 50, 1086. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "50,"

Phrase: "1086."
Processing 00000000.tx.139: 13. 

Phrase: "13."
Processing 00000000.tx.140: Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T. and Delon, M.R. 

Phrase: "Whitehouse,"

Phrase: "P.J.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "L., Struble,"

Phrase: "R.G.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Clark,"

Phrase: "A.W., Coyle,"

Phrase: "J.T."

Phrase: "and"

Phrase: "Delon,"

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.141: (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "senile dementia"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0002395:Dementia, Senile [Disease or Syndrome]
  1000   C0011268:Senile dementia [Mental or Behavioral Dysfunction]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0392079:Senile [Finding]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ":"

Phrase: "loss of neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0598940:Loss of neurons [Finding]
           neuron loss
   816 E C1850496:Neuronal loss [Finding]
   790   C1517945:Loss [Quantitative Concept]

Phrase: "in the basal forebrain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2331620:Basal forebrain [Body Part, Organ, or Organ Component]
   861   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]
   861   C0205112:Basal [Spatial Concept]
Processing 00000000.tx.142: Science, 215, 1237-1239. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "215,"

Phrase: "1237-1239."
Processing 00000000.tx.143: MEDLINE Abstract 14. 

Phrase: "MEDLINE Abstract 14."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.144: Geula, C. and Mesulam, M.M. 

Phrase: "Geula,"

Phrase: "C."

Phrase: "and"

Phrase: "Mesulam,"

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.145: (1995) Cholinesterases and the pathology of Alzheimer disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cholinesterases"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0008429:Cholinesterases [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the pathology of Alzheimer disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.146: Alzheimer Dis. 

Phrase: "Alzheimer Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451119:DIS [Intellectual Product]
   861   C1444662:DIS [Finding]
Processing 00000000.tx.147: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.148: Disord., 9, 23-28. 

Phrase: "Disord.,"

Phrase: "9,"

Phrase: "23-28."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.149: MEDLINE Abstract 15. 

Phrase: "MEDLINE Abstract 15."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.150: Gomez-Ramos, P., Bouras, C. and Moran, M.A. 

Phrase: "Gomez-Ramos,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bouras,"

Phrase: "C."

Phrase: "and"

Phrase: "Moran,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945650:moran [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.151: (1994) Ultrastructural localization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer's disease patients. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Ultrastructural localization of butyrylcholinesterase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "on neurofibrillary degeneration sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
   734   C0085400:Neurofibrillary degeneration [Acquired Abnormality]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "and"

Phrase: "Alzheimer's disease patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.152: Brain Res., 640, 17-24. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "640,"

Phrase: "17-24."
Processing 00000000.tx.153: MEDLINE Abstract 16. 

Phrase: "MEDLINE Abstract 16."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.154: Christie, J., Lamb, H., Singleton, A.B., Leake, A., Melton, L.M., Perry, R.H., McKeith, I.G. and Morris, C.M. 

Phrase: "Christie,"

Phrase: "J.,"

Phrase: "Lamb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0452875:Lamb [Food]
  1000   C1123019:lamb [Mammal]
  1000   C1145701:L-AmB [Antibiotic,Organic Chemical]
  1000   C3496086:Lamb [Organic Chemical,Pharmacologic Substance]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "Leake,"

Phrase: "A.,"

Phrase: "Melton,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Perry,"

Phrase: "R.H.,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "McKeith,"

Phrase: "I.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Morris,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.155: (1996) Determination on the alpha-1 anti-chymotrypsin polymorphism in Alzheimer's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Determination on the alpha-1 anti-chymotrypsin polymorphism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1148554:determination [Laboratory Procedure]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.156: Alzheimer Res., 2, 201-204. 

Phrase: "Alzheimer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "201-204."
Processing 00000000.tx.157: 17. 

Phrase: "17."
Processing 00000000.tx.158: Singleton, A.B., Gibson, A.M., Atkinson, A.L., Daly, A. and Morris, C.M. 

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "Gibson,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Atkinson,"

Phrase: "A.L., Daly,"

Phrase: "A."

Phrase: "and"

Phrase: "Morris,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.159: (1997) Presenilin polymorphisms in Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Presenilin polymorphisms in Alzheimer's disease."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0032529:polymorphisms [Genetic Function]
   726 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.160: Lancet, 350, 958-959. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "350,"

Phrase: "958-959."
Processing 00000000.tx.161: MEDLINE Abstract 18. 

Phrase: "MEDLINE Abstract 18."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.162: Pericak-Vance, M.A., Bass, M.P., Yamaoka, L.H., Gaskell, P.C., Scott, W.K., Terwedow, H.A., Menold, M.M., Conneally, P.M., Small, G.W., Vance, J.M., Saunders, A.M., Roses, A.D. and Haines, J.L. 

Phrase: "Pericak-Vance,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bass,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004830:Bass [Fish]

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Yamaoka,"

Phrase: "L.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Scott,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Terwedow,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "A.,"

Phrase: "Menold,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "Conneally,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G.W., Vance,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "Haines,"

Phrase: "J.L."
Processing 00000000.tx.163: (1997) Complete genomic screen in late-onset familial Alzheimer disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "genomic screen in late-onset familial Alzheimer disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0220908:screen [Health Care Activity]
   744   C1305399:screen [Functional Concept]
   744   C1705053:Screen [Medical Device]
   703   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
Processing 00000000.tx.164: Evidence for a new locus on chromosome 12. 

Phrase: "Evidence for a new locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "on chromosome 12."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008654:Chromosome 12 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.165: J. 

Phrase: "J."
Processing 00000000.tx.166: Am. 

Phrase: "Am."
Processing 00000000.tx.167: Med. 

Phrase: "Med."
Processing 00000000.tx.168: Assoc., 278, 1237-1241. 

Phrase: "Assoc.,"

Phrase: "278,"

Phrase: "1237-1241."
Processing 00000000.tx.169: 19. 

Phrase: "19."
Processing 00000000.tx.170: Morris, C.M., Massey, H.M., Benjamin, R., Leake, A., Broadbent, C., Griffiths, M., Lamb, H., Brown, A., Ince, P.G., Tyrer, S., Thompson, P., McKeith, I.G., Edwardson, J.A., Perry, R.H. and Perry, E.K. 

Phrase: "Morris,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Massey,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Benjamin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442989:Benjamin [Intellectual Product]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Leake,"

Phrase: "A.,"

Phrase: "Broadbent,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Griffiths,"

Phrase: "M."

Phrase: ","

Phrase: "Lamb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0452875:Lamb [Food]
  1000   C1123019:lamb [Mammal]
  1000   C1145701:L-AmB [Antibiotic,Organic Chemical]
  1000   C3496086:Lamb [Organic Chemical,Pharmacologic Substance]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "A.,"

Phrase: "Ince,"

Phrase: "P.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Tyrer,"

Phrase: "S."

Phrase: ","

Phrase: "Thompson,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "McKeith,"

Phrase: "I.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Edwardson,"

Phrase: "J."

Phrase: "A.,"

Phrase: "Perry,"

Phrase: "R.H."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Perry,"

Phrase: "E.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.171: (1996) Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Molecular biology of APO E alleles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   760   C0005532:Biology [Biomedical Occupation or Discipline]
   760   C1521991:Molecular [Qualitative Concept]

Phrase: "in Alzheimer's"

Phrase: "and"

Phrase: "non-Alzheimer's dementias."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C0002395:Alzheimer's Dementia [Disease or Syndrome]
   827   C0497327:Dementias [Mental or Behavioral Dysfunction]
   827   C1518422:Non [Functional Concept]
   793 E C0011265:dementia [Mental or Behavioral Dysfunction]
   721 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.172: J. 

Phrase: "J."
Processing 00000000.tx.173: Neural Transm., 47, 205-218. 

Phrase: "Neural Transm.,"

Phrase: "47,"

Phrase: "205-218."
Processing 00000000.tx.174: 20. 

Phrase: "20."
Processing 00000000.tx.175: Cross, R.B. 

Phrase: "Cross,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "R.B."
Processing 00000000.tx.176: (1982) Demonstration of neurofibrillary tangles in paraffin sections: a quick and simple method using Palmgren's technique. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Demonstration of neurofibrillary tangles"

Phrase: "in paraffin sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: ":"

Phrase: "a quick"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:quick [Qualitative Concept]

Phrase: "and"

Phrase: "simple method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Palmgren's technique."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449851:Technique [Functional Concept]
   777 E C0025664:techniques [Intellectual Product]
Processing 00000000.tx.177: Med. 

Phrase: "Med."
Processing 00000000.tx.178: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.179: Sci., 39, 67-69. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "39,"

Phrase: "67-69."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]
Processing 00000000.tx.180: MEDLINE Abstract *To whom correspondence should be addressed. 

Phrase: "MEDLINE Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0000857:Abstract [Occupational Activity]
   861   C0600678:Abstract [Intellectual Product]
   861   C1552863:Abstract [Idea or Concept]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.181: Tel: +44 191 273 5251; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+44 191 273 5251"

Phrase: ";"
Processing 00000000.tx.182: Fax: +44 191 272 5291; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+44 191 272 5291"

Phrase: ";"
Processing 00000000.tx.183: Email a.b.singleton@ncl.ac.uk This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals Comments and feedback: www-admin{at}oup.co.uk Last modification: 4 Apr 1998 Copyright Oxford University Press, 1998.

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "a.b.singleton@ncl.ac.uk"

Phrase: "This page"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "is"

Phrase: "run by Oxford University Press,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0035953:run [Daily or Recreational Activity]
   760   C0041740:University [Manufactured Object,Organization]
   760   C0600140:run [Finding]
   760   C1704688:Run [Functional Concept]
   760   C2346414:Run [Finding]

Phrase: "Great Clarendon Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442658:Street [Manufactured Object]
   827   C1301826:Street [Finding]

Phrase: "Oxford OX2 6DP,"

Phrase: "as"

Phrase: "part of the OUP Journals Comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "feedback"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015744:Feedback [Phenomenon or Process]
  1000   C2911691:Feedback [Mental Process]

Phrase: ":"

Phrase: "www-admin{at}oup.co.uk Last modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]

Phrase: ":"

Phrase: "4 Apr 1998 Copyright Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0041740:University [Manufactured Object,Organization]

Phrase: "1998."

